Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide.
about
Impact of parathyroid hormone on bone marrow-derived stem cell mobilization and migrationParathyroid hormone and parathyroid hormone type-1 receptor accelerate myocyte differentiation.Primary hyperparathyroidism of postmenopausal women. Prospective population-based case-control analysis on prevalence, clinical findings and treatment. Minireview based on a doctoral thesis.Effect of intermittent versus continuous parathyroid hormone in the cardiovascular system of rats.EBP50 inhibits the anti-mitogenic action of the parathyroid hormone type 1 receptor in vascular smooth muscle cells.Parathyroidectomy improves survival in patients with severe hyperparathyroidism: a comparative studySecondary hyperparathyroidism and target organs in chronic kidney disease.The effects of super-flux (high performance) dialyzer on plasma glycosylated pro-B-type natriuretic peptide (proBNP) and glycosylated N-Terminal proBNP in end-stage renal disease patients on dialysis.Improved long-term survival of dialysis patients after near-total parathyroidectomy.The calcium-sensing receptor and calcimimetics in blood pressure modulationSinus node dysfunction secondary to hyperparathyroidism.Cardiovascular diseases in older patients with osteoporotic hip fracture: prevalence, disturbances in mineral and bone metabolism, and bidirectional linksSerum 25-hydroxyvitamin D and parathyroid hormone in relation to plasma B-type natriuretic peptide: the Hoorn StudyOsteopontin negatively regulates parathyroid hormone receptor signaling in osteoblastsEndogenous parathyroid hormone-related protein regulates the expression of PTH type 1 receptor and proliferation of vascular smooth muscle cells.Serum vitamin D, intact parathyroid hormone, and Fetuin A concentrations were associated with geriatric sarcopenia and cardiac hypertrophy.Early origins of cardiovascular disease in pediatric chronic kidney disease.Target levels for serum phosphorus and parathyroid hormone.Parathyroid hormone, a crucial mediator of pathologic cardiac remodeling in aldosteronism.Parathyroid enlargement at dialysis initiation in patients with chronic kidney diseases.Muscle-bone and fat-bone interactions in regulating bone mass: do PTH and PTHrP play any role?Management of secondary hyperparathyroidism: how and why?Parathyroid Hormone-Related Peptide: A Novel Endocrine Cardioprotective "Conditioning Mimetic".Secondary hyperparathyroidism prevalence and prognostic role in elderly males with heart failure.The Parathyroid Gland and Heart Disease.Parathyroid hormone accelerates decompensation following left ventricular hypertrophy.Knockdown of parathyroid hormone related protein in smooth muscle cells alters renal hemodynamics but not blood pressure.Mechanisms of PTHrP-induced inhibition of smooth muscle contractility in the guinea pig gastric antrum.Parathyroid hormone-related protein-(1-34) inhibits intrinsic pump activity of isolated murine lymph vessels.Serum parathyroid hormone levels predict coronary heart disease: the Tromsø Study.Serum 25-hydroxyvitamin D and left ventricular systolic function in a non-smoking population: the Tromsø Study.Rat parathyroid hormone 1-34 signals through the MEK/ERK pathway to induce cardiac hypertrophy.Effect of pharmacological suppression of secondary hyperparathyroidism on cardiovascular hemodynamics in predialysis CKD patients: A preliminary observation.Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways.Parathyroid hormone 1-84 targets bone vascular structure and perfusion in mice: impacts of its administration regimen and of ovariectomy.Is serum phosphate a useful target in patients with chronic kidney disease and what is the role for dietary phosphate restriction?Vitamin D3 and the risk of CVD in overweight and obese women: a randomised controlled trial.Comparison of parathyroid hormone and G-CSF treatment after myocardial infarction on perfusion and stem cell homing.Predictors of acquired perforating dermatosis in uremic patients on hemodialysis: a case-control study.Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome
P2860
Q27000094-2AD2E9B9-22A3-414D-BA89-5A58B665FAD0Q30580472-9DD5CA4A-7118-46D2-B33D-30ABCD636C5FQ33697089-C05EC002-4612-4F3B-92CB-151F9011F74FQ33837249-E13D2F5B-863D-43E9-A768-CB665EFD6E89Q34288743-4946DE45-1F2E-4273-8DC4-A4E79823CBE1Q34934411-B059127D-B9BF-4B78-8F33-04B00DF31221Q35115557-7D977E9E-289A-4C96-8D9E-50F1CF865DD3Q35131225-16F1A712-6080-44F2-93B3-8B360E316546Q35146504-13E6BE08-AD14-4E14-B210-BF4FDAAD9F23Q35376000-D212C8EE-FB32-4CB7-B1F2-B3ED77FD5800Q35862171-65CB3B01-E69A-4ABF-BCE2-0C93F4F1301CQ36648170-232414EB-1F28-4A82-B8F6-33ACC44BD424Q36928027-BEC7B685-3B09-432E-A27E-F7351DE56E4FQ37145720-48E1D910-E5A5-4D67-AEE7-44FD96D2647BQ37369770-FC48F70A-DDE7-4564-A6DC-8219E17C9399Q37598481-72D317B6-4F2F-4AD6-AF67-D24BC498FB72Q37683776-1A66A759-E988-4E3B-913F-B44544F89E78Q37842762-D56BA89F-1E01-4A07-B344-1AB970CF3D68Q37988979-58F4F071-0213-47D1-ADE2-154801E5B7E6Q38078963-6A88330A-5BF4-47CF-8DB4-7E158FFF53C5Q38209810-CEC64677-860F-4BF6-A3A5-E347B2F6365AQ38775426-4E1F7E6B-87C4-4D3B-B179-471DAE43E75DQ39238269-6AE53D71-A09E-468B-8502-643DD20D6A28Q40542661-25AEFD74-163E-4696-B64F-C86BF4B40B8AQ41030014-9BFD9C97-89FB-40F7-AA71-8EEB3A313B58Q41891365-411A0E7F-FB4E-4813-A445-588EBCCBCA57Q42439232-FC895D2D-FE99-40AC-A19D-B152A41BD716Q42511629-CC13CEE7-3030-4171-8C84-743BA0BB70D6Q43640236-73A98C6E-5260-4900-9112-A75CBAE72982Q44913559-9291DD63-3867-460D-9B37-D25FE0430E30Q45212999-185EB646-BAAB-453B-B6E6-7475A3B5AE0EQ46334588-0A10E60D-E138-4915-A981-25BC28B4ADF8Q46961168-72D66E45-6B82-4FAF-93E6-26A281265856Q50703452-0506C946-45D7-4569-88F0-A8869CA26076Q51163702-3ED6D285-946E-4ABE-B0D7-934536E4A5F5Q52674802-4290A03F-D710-4DC6-8616-AFC1CDFC07E6Q53135887-3439150E-70FB-417C-9F5E-58694BF36245Q53305885-83D44E1E-0C74-489E-A345-9F4A9A39C709Q55504665-BEDC5FBE-78F2-4E2B-85BB-A39372F60124Q58773641-D234DF5D-EA63-49A3-A04C-5EB1293946B1
P2860
Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide.
@en
type
label
Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide.
@en
prefLabel
Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide.
@en
P2860
P1476
Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide.
@en
P2093
P2860
P356
10.1016/S0008-6363(97)00194-6
P577
1998-01-01T00:00:00Z